Exact Mass: 468.272304
Exact Mass Matches: 468.272304
Found 500 metabolites which its exact mass value is equals to given mass value 468.272304
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Gentamicin A
C18H36N4O10 (468.24313159999997)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins
Clinofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Clinofibrate (S-8527) is a hypelipidemic agent and a HMG-CoA reductase inhibitor.
3,17-Androstanediol glucuronide
3,17-Androstanediol glucuronide is a natural human metabolite of 3,17-Androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
3-alpha-Androstanediol glucuronide
3-alpha-androstanediol glucuronide is a natural human metabolite of 3-alpha-androstanediol generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.
17-Hydroxyandrostane-3-glucuronide
17-hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. 17-Hydroxyandrostane-3-glucuronide is a natural human metabolite of 17-hydroxyandrostane generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione
(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione is found in herbs and spices. (17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione is a constituent of Muscari comosum (tassel hyacinth)
hydroxyrepaglinide
hydroxyrepaglinide is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. (Wikipedia)
3alpha-Androstanediol glucuronide
Androstanediol-17g
Antcin B
Clinofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent Clinofibrate (S-8527) is a hypelipidemic agent and a HMG-CoA reductase inhibitor.
Gentamicin A sulfate
C18H36N4O10 (468.24313159999997)
Ivabradine
DG(2:0/PGE2/0:0)
DG(2:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGE2/2:0/0:0)
DG(PGE2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGE2)
DG(2:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGE2/0:0/2:0)
DG(PGE2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/PGD2/0:0)
DG(2:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(PGD2/2:0/0:0)
DG(PGD2/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/PGD2)
DG(2:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(PGD2/0:0/2:0)
DG(PGD2/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)
DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0)
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))
DG(2:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0)
DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
Cardivin B
A germacranolide isolated from the aerial parts of Carpesium divaricatum. It exhibits cytotoxicity against the human tumor cells, A-549 (nonsmall cell lung), SK-OV-3 (ovary), SK-MEL-2 (skin), XF-498 (central nervous system) and HCT-15 (colon).
Zhankuic acid A
A steroid acid that is ergosta-8,24(28)-dien-26-oic acid substituted by a methyl group at position 4 and oxo groups at positions 3, 7 and 11 (the 4alpha,5alpha stereoisomer). Isolated from Antrodia cinnamomea and Antrodia camphorata, it exhibits cytotoxic and anti-inflammatory activity.
6,7-Epoxy-5-hydroxy-27-methyl-1-oxowitha-2,24-dienolide
(6S,13S)-cleroda-3,14-diene-6,13-diol 6-O-beta-D-glucopyranoside|alpha-vinyl-1,2,3,4,4a,7,8,8a-octahydro-alpha,1,2,4a,5-pentamethyl-1-naphthalenepropanol 4-O-beta-glucopyranoside
11alpha,12beta-dihydroxy-(20R,22R)-21,24-epoxy-1-oxowitha-2,5,25(27)-trien-22,26-olide|witharifeen
10-hydroxydihydrousambarine|10-Hydroxynigritanin|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-10-ol|18, 19-Dihydrousambaridine Vi
(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-9,23-dihydroxyergosta-4,7,11-triene-3,6-dione|blazeispirol Y
(22R,Z)-4beta,16beta,27-trihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide|(4S,22R,Z)-4,16beta,27-trihydroxy-1-oxo-witha-2,5,17(20),24-tetraenolide
stemodin 13-O-beta-D-glucopyranoside|stemodinoside B
2-((2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl)-6-methylhydroquinol|2-<(2E,6E,10E)-5-acetoxy-3,7,11,15-tetramethyl-12-oxohexadeca-2,6,10,14-tetraenyl>-6-methylhydroquinol
eucalyptal C
An organic heterotetracyclic compound whose skeleton is composed of 3,5-diformyl-isopentyl substituted phloroglucinol fused with a cadinane ring system. Isolated from Eucalyptus globulus, it exhibits antineoplastic activity.
alpha-eudesmol-beta-D-glucopyranoside-6O-isovalerate
18-hydroxy-27-norolean-12,14-dien-30-al-28-oic acid
20alpha-hydroxy-1,4-dioxo-5beta,6beta-epoxy-20R,22R-witha-2,24-dienolide
24-Methyl-26,27-bisnor-22-cholestene-3,4,6,8,15,16,25-heptol
11-hydroxydihydrousambarine|16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-11-ol|18, 19-Dihydrousambaridine Br|18,19-Dihydro-usambaridin Br
(4R,13S)-18-O-beta-D-glucopyranosyllabda-8(17),14-dien-13-ol|{(1R,4aR,5S,8aR)-decahydro-1,4a-dimethyl-6-methylide-5-[(3S)-3-hydroxy-3-methylpent-4-en-1-yl]naphthalen-1-yl}methyl beta-D-glucopyranoside
4alpha-acetoxy-3alpha-(3-acetoxy-2-methylbutyryloxy)-11-hydroxy-6,7-dehydroeudesman-8-one
(22R)-27-hydroxy-7alpha-methoxy-1-oxowitha-3,5,24-trienolide
(3S,5S,10S,13R,17S,23S,24S)-21,23-lactone-3,24-dihydroxystigmasta-8,14,20-trien-28-one|vernoanthelcin H
withahisolide A|[(5R,6S,7S,8S,9S,10R,14S,20S,22R,24S,25S,26R)-6alpha,7alpha:22,26:24,25-triepoxy-5alpha,26-dihydroxy-17(13?18)-abeo-5alpha-ergost-2,12,16-trien-1-one]
10beta-dihydroxy-6alpha-2-methylbutyloxy-9beta-isobutyloxy-germacran-8alpha,12-olide|ineupatolide C
withahisolide B|[(5R,6S,7S,8S,9S,10R,20S,22R,24S,25S,26R)-6alpha,7alpha:22,26:24,25-triepoxy-5alpha,26-dihydroxy-17(13?18)-abeo-5alpha-ergost-2,13,16-trien-1-one]
4beta,8alpha-dihydroxy-5beta-isobutyroyloxy-9beta-(3-methylbutyroyloxy)-3-oxo-germacr-11(13)-en-7beta,12alpha-olide
(13S)-ent-18-(E)-coumaroyloxy-8(17)-labden-15-oic acid
1alpha-hydroxy-ent-13-epi-manoyl oxide 1-O-beta-D-galactopyranoside|phaeoside
3beta,16alpha-dihydroxy-ent-kaurane-3-O-beta-D-glucopyranoside
Maoyerabdosin
Maoyerabdosin is a natural product found in Isodon macrocalyx and Isodon japonicus with data available.
16-(2-methyl-2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-corynan-12-ol|18,19-Dihydro-usambaridin Vi
eucalyptal A
An organic heterotetracyclic compound whose skeleton is composed of 3,5-diformyl-isopentyl substituted phloroglucinol fused with a cadinane ring system. Isolated from Eucalyptus globulus, it exhibits antineoplastic activity.
16alpha,19-dihydroxy-ent-kaurane 19-O-beta-D-glucopyranoside
4-DWA
4-Dehydrowithaferin A is a natural product found in Withania aristata with data available.
CID 73554066
Ala His Lys Asn
C19H32N8O6 (468.24446919999997)
Ala His Asn Lys
C19H32N8O6 (468.24446919999997)
Ala Lys His Asn
C19H32N8O6 (468.24446919999997)
Ala Lys Asn His
C19H32N8O6 (468.24446919999997)
Ala Asn His Lys
C19H32N8O6 (468.24446919999997)
Ala Asn Lys His
C19H32N8O6 (468.24446919999997)
Phe Phe Gly Val
Phe Phe Val Gly
Phe Gly Phe Val
Phe Gly Val Phe
Phe Val Phe Gly
Phe Val Gly Phe
Gly Phe Phe Val
Gly Phe Val Phe
Gly His Lys Lys
Gly His Lys Gln
C19H32N8O6 (468.24446919999997)
Gly His Gln Lys
C19H32N8O6 (468.24446919999997)
Gly Lys His Lys
Gly Lys His Gln
C19H32N8O6 (468.24446919999997)
Gly Lys Lys His
Gly Lys Gln His
C19H32N8O6 (468.24446919999997)
Gly Gln His Lys
C19H32N8O6 (468.24446919999997)
Gly Gln Lys His
C19H32N8O6 (468.24446919999997)
Gly Val Phe Phe
His Ala Lys Asn
C19H32N8O6 (468.24446919999997)
His Ala Asn Lys
C19H32N8O6 (468.24446919999997)
His Gly Lys Lys
His Gly Lys Gln
C19H32N8O6 (468.24446919999997)
His Gly Gln Lys
C19H32N8O6 (468.24446919999997)
His Ile Ile Ser
His Ile Leu Ser
His Ile Ser Ile
His Ile Ser Leu
His Ile Thr Val
His Ile Val Thr
His Lys Ala Asn
C19H32N8O6 (468.24446919999997)
His Lys Gly Lys
His Lys Gly Gln
C19H32N8O6 (468.24446919999997)
His Lys Lys Gly
His Lys Asn Ala
C19H32N8O6 (468.24446919999997)
His Lys Gln Gly
C19H32N8O6 (468.24446919999997)
His Leu Ile Ser
His Leu Leu Ser
His Leu Ser Ile
His Leu Ser Leu
His Leu Thr Val
His Leu Val Thr
His Asn Ala Lys
C19H32N8O6 (468.24446919999997)
His Asn Lys Ala
C19H32N8O6 (468.24446919999997)
His Gln Gly Lys
C19H32N8O6 (468.24446919999997)
His Gln Lys Gly
C19H32N8O6 (468.24446919999997)
His Ser Ile Ile
His Ser Ile Leu
His Ser Leu Ile
His Ser Leu Leu
His Thr Ile Val
His Thr Leu Val
His Thr Val Ile
His Thr Val Leu
His Val Ile Thr
His Val Leu Thr
His Val Thr Ile
His Val Thr Leu
Ile His Ile Ser
Ile His Leu Ser
Ile His Ser Ile
Ile His Ser Leu
Ile His Thr Val
Ile His Val Thr
Ile Ile His Ser
Ile Ile Ser His
Ile Leu His Ser
Ile Leu Ser His
Ile Ser His Ile
Ile Ser His Leu
Ile Ser Ile His
Ile Ser Leu His
Ile Thr His Val
Ile Thr Val His
Ile Val His Thr
Ile Val Thr His
Lys Ala His Asn
C19H32N8O6 (468.24446919999997)
Lys Ala Asn His
C19H32N8O6 (468.24446919999997)
Lys Gly His Lys
Lys Gly His Gln
C19H32N8O6 (468.24446919999997)
Lys Gly Lys His
Lys Gly Gln His
C19H32N8O6 (468.24446919999997)
Lys His Ala Asn
C19H32N8O6 (468.24446919999997)
Lys His Gly Lys
Lys His Gly Gln
C19H32N8O6 (468.24446919999997)
Lys His Lys Gly
Lys His Asn Ala
C19H32N8O6 (468.24446919999997)
Lys His Gln Gly
C19H32N8O6 (468.24446919999997)
Lys Lys Gly His
Lys Lys His Gly
Lys Lys Pro Pro
C22H40N6O5 (468.30600300000003)
Lys Asn Ala His
C19H32N8O6 (468.24446919999997)
Lys Asn His Ala
C19H32N8O6 (468.24446919999997)
Lys Pro Lys Pro
C22H40N6O5 (468.30600300000003)
Lys Pro Pro Lys
C22H40N6O5 (468.30600300000003)
Lys Pro Pro Gln
Lys Pro Gln Pro
Lys Gln Gly His
C19H32N8O6 (468.24446919999997)
Lys Gln His Gly
C19H32N8O6 (468.24446919999997)
Lys Gln Pro Pro
Leu His Ile Ser
Leu His Leu Ser
Leu His Ser Ile
Leu His Ser Leu
Leu His Thr Val
Leu His Val Thr
Leu Ile His Ser
Leu Ile Ser His
Leu Leu His Ser
Leu Leu Ser His
Leu Ser His Ile
Leu Ser His Leu
Leu Ser Ile His
Leu Ser Leu His
Leu Thr His Val
Leu Thr Val His
Leu Val His Thr
Leu Val Thr His
Asn Ala His Lys
C19H32N8O6 (468.24446919999997)
Asn Ala Lys His
C19H32N8O6 (468.24446919999997)
Asn His Ala Lys
C19H32N8O6 (468.24446919999997)
Asn His Lys Ala
C19H32N8O6 (468.24446919999997)
Asn Lys Ala His
C19H32N8O6 (468.24446919999997)
Asn Lys His Ala
C19H32N8O6 (468.24446919999997)
Pro Lys Lys Pro
C22H40N6O5 (468.30600300000003)
Pro Lys Pro Lys
C22H40N6O5 (468.30600300000003)
Pro Lys Pro Gln
Pro Lys Gln Pro
Pro Pro Lys Lys
C22H40N6O5 (468.30600300000003)
Pro Pro Lys Gln
Pro Pro Gln Lys
Pro Gln Lys Pro
Pro Gln Pro Lys
Gln Gly His Lys
C19H32N8O6 (468.24446919999997)
Gln Gly Lys His
C19H32N8O6 (468.24446919999997)
Gln His Gly Lys
C19H32N8O6 (468.24446919999997)
Gln His Lys Gly
C19H32N8O6 (468.24446919999997)
Gln Lys Gly His
C19H32N8O6 (468.24446919999997)
Gln Lys His Gly
C19H32N8O6 (468.24446919999997)
Gln Lys Pro Pro
Gln Pro Lys Pro
Gln Pro Pro Lys
Ser His Ile Ile
Ser His Ile Leu
Ser His Leu Ile
Ser His Leu Leu
Ser Ile His Ile
Ser Ile His Leu
Ser Ile Ile His
Ser Ile Leu His
Ser Leu His Ile
Ser Leu His Leu
Ser Leu Ile His
Ser Leu Leu His
Thr His Ile Val
Thr His Leu Val
Thr His Val Ile
Thr His Val Leu
Thr Ile His Val
Thr Ile Val His
Thr Leu His Val
Thr Leu Val His
Thr Val His Ile
Thr Val His Leu
Thr Val Ile His
Thr Val Leu His
Val Phe Phe Gly
Val Phe Gly Phe
Val Gly Phe Phe
Val His Ile Thr
Val His Leu Thr
Val His Thr Ile
Val His Thr Leu
Val Ile His Thr
Val Ile Thr His
Val Leu His Thr
Val Leu Thr His
Val Thr His Ile
Val Thr His Leu
Val Thr Ile His
Val Thr Leu His
18-acetoxy-PGF2α-11-acetate methyl ester
(5Z,7E,22E)-(1S,3R,25R)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol
(5Z,7E,22E)-(1S,3R,25S)-26,26,26-trifluoro-9,10-seco-5,7,10(19),22-cholestatetraene-1,3,25-triol
(7E)-(3S, 6RS)-6,19-epidioxy-24,24-difluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol
3,17-Androstanediol glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
3-alpha-androstanediol glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
(17alpha,23S)-17,23-Epoxy-29-hydroxy-27-norlanosta-1,8-diene-3,15,24-trione
(3?,5?,8?,9?,10?,16?)-16-Hydroxykauran-3-yl ?-D-glucopyranoside
(22E)-(25R)-26,26,26-trifluoro-1alpha,25-dihydroxy-22,23-didehydrovitamin D3
C27H39O3F3 (468.28511399999996)
(22E)-(25S)-26,26,26-trifluoro-1alpha,25-dihydroxy-22,23-didehydrovitamin D3
C27H39O3F3 (468.28511399999996)
(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3
C27H42O4F2 (468.30509960000006)
ST 19:0;O2;GlcA
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
tert-butyliminotantalum,diethylazanide
C16H39N4Ta (468.26546940000003)
4-[(S,S)-2,3-EPOXYHEXYLOXY]PHENYL 4-(DECYLOXY)BENZOATE
Ivabradine
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C - Cardiovascular system > C01 - Cardiac therapy D002317 - Cardiovascular Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
morfamquat (ISO) 1,1-bis(3,5-dimethylmorpholinocarbonylmethyl)-4,4-bipyridilium ion
4-[(3-ethenyl-6,10,10b-trihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-5,6,6a,8,9,10-hexahydro-2H-benzo[f]chromen-5-yl)oxy]-4-oxobutanoic acid
HTH 01-015
HTH-01-015 is a selective NUAK1/ARK5 inhibitor (IC50 is 100 nM). HTH-01-015 inhibits NUAK1 with >100-fold higher potency than NUAK2 (IC50 of >10 μM).
(S)-benzyl 2-((S)-2-(tert-butoxycarbonylamino)-4-methylpentanamido)-3-phenylpropanoate
2,6-DIMETHYL-4-HEPTYL-B-D-MALTOPYRANOSIDE, ANAGRADE?
C21H40O11 (468.25704900000005)
n-nonyl-b-d-maltopyranoside, anagrade
C21H40O11 (468.25704900000005)
5alpha-Androstane-3beta,17beta-diol 17-glucuronide
(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrovitamin D3/(6RS)-6,19-epidioxy-24,24-difluoro-25-hydroxy-6,19-dihydrocholecalciferol
(1R)-1-[[(2S,3R,11bS)-3-ethyl-9,10-dimethoxy-1,2,3,4,5,6,7,11b-octahydrobenzo[a]quinolizin-5-ium-2-yl]methyl]-7-methoxy-1,2,3,4-tetrahydroisoquinolin-2-ium-6-ol
C28H40N2O4+2 (468.29879200000005)
Klugine
An isoquinoline alkaloid that is emetan substituted by methoxy groups at positions 7 and 11 and hydroxy groups at positions 1, 6 and 10. Isolated from Psychotria klugii, it exhibits antileishmanial and antiplasmodial activities.
Tubocapsanolide A
A withanolide that is 5beta,6beta:16alpha,17alpha-diepoxywitha-2,24-dienolide substituted by a hydroxy group at position 4 and an oxo group at position 1. Isolated from Tubocapsicum anomalum, it exhibits cytotoxic activity.
calotropone
A 20-oxo steroid that is 17alpha-pregn-5-en-20-one substituted by a benzoyloxy group at position 12 and hydroxy groups at positions 3, 14 and 17 (the 3beta,12beta,14beta stereoisomer). It is isolated from the roots of Calotropis gigantea and displays inhibitory effects towards chronic myelogenous leukemia K562 and human gastric cancer SGC-7901 cell lines.
Breynceanothanolic acid
A triterpenoid of the nor-ceanothane-type isolated from the roots of Breynia fruticosa and has been shown to exhibit cytotoxicity against human cancer cell lines.
Minabeolide 5
A withanolide that is (22R,25S)-22,26-epoxycholesta-1,4-dien-26-one substituted by an oxo group at position 3 and an acetoxy group at position 18. Isolated from Paraminabea acronocephala, it exhibits anti-inflammatory activity.
3alpha-androstanediol glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
ethyl 4-[[(2S)-4-methyl-1-oxo-1-[[(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]pentan-2-yl]carbamoyloxy]piperidine-1-carboxylate
acetic acid [(1R,4bR,5R,10aR,12aR)-1-(3-furanyl)-4b,7,7,10a,12a-pentamethyl-3,8-dioxo-5,6,6a,9,10,10b,11,12-octahydro-1H-naphtho[2,1-f][2]benzopyran-5-yl] ester
1-[(1-ethyl-3,4-dihydro-2H-quinolin-6-yl)methyl]-3-(3-methoxyphenyl)-1-[2-(4-morpholinyl)ethyl]thiourea
(1S,9R,10R,11R)-11-N-ethyl-10-(hydroxymethyl)-5-(2-methoxyphenyl)-6-oxo-12-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
propan-2-yl N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
propan-2-yl N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
propan-2-yl N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(2R,3R,3aS,9bS)-7-(2-fluorophenyl)-3-(hydroxymethyl)-2-(4-methylpiperazine-1-carbonyl)-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
propan-2-yl N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
2-(dimethylamino)-N-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
2-[(3R,6aS,8S,10aS)-1-[(4-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H33FN2O4 (468.24242300000003)
1-[(1S)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone
1-[[(2S,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3S)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3R)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2R,3R)-9-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
1-[[(2S,3S)-9-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-2-yl]methyl]-1-methyl-3-phenylurea
2-(dimethylamino)-N-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
2-(dimethylamino)-N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(4-methylphenyl)-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(pyridin-4-ylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(pyridin-4-yl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-[oxo(2-pyridinyl)methyl]-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-[oxo(3-pyridinyl)methyl]-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyridinecarboxamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-(3-pyridinylmethyl)-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide
propan-2-yl N-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
(3R,6aR,8S,10aR)-3-hydroxy-8-[2-oxo-2-(2-pyridin-4-ylethylamino)ethyl]-N-phenyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
(1R,9S,10S,11S)-11-N-ethyl-10-(hydroxymethyl)-5-(2-methoxyphenyl)-6-oxo-12-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(2S,3S,3aR,9bR)-7-(2-fluorophenyl)-3-(hydroxymethyl)-2-[(4-methyl-1-piperazinyl)-oxomethyl]-1-propyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
propan-2-yl N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
propan-2-yl N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-N-methylcarbamate
1-[(1R)-2-[cyclopropyl(oxo)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(dimethylamino)ethanone
[O-(2-O-Tetradecanoyl-L-glycero-3-phospho)choline]anion
2-[(3R,6aS,8S,10aS)-1-[(2-fluorophenyl)methyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
C27H33FN2O4 (468.24242300000003)
2-[[(2R)-3-heptanoyloxy-2-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[[(2R)-2-heptanoyloxy-3-hexanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[[(2R)-2-acetyloxy-3-dodecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [3-[(Z)-hexadec-9-enoxy]-2-hydroxypropyl] hydrogen phosphate
[3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-pentadec-9-enoate
2-[(2-Heptanoyloxy-3-hexanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[(2-Acetyloxy-3-dodecoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-hydroxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
2-[(3-Acetyloxy-2-undecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[(2-Decanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[Hydroxy-(2-octanoyloxy-3-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[(3-Butanoyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
C21H43NO8P+ (468.27261480000004)
2-[(2-Hexanoyloxy-3-octoxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[Hydroxy-(3-nonoxy-2-pentanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium
5alpha-androstane-3beta,17beta-diol 3-O-(beta-D-glucuronide)
A steroid glucosiduronic acid that is 5alpha-androstane-3beta,17beta-diol having a single beta-D-glucuronic acid residue attached at position 3. It is a biochemical marker of peripheral tissue androgen metabolism.
17-hydroxyandrostane-3-glucuronide
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones